AbCellera Biologics Inc. (FRA:8QQ)
Germany
· Delayed Price · Currency is EUR 3.000
-0.040 (-1.32%)
At close: Dec 4, 2025
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of €916.02 million as of December 5, 2025. Its market cap has increased by 23.70% in one year.
Market Cap
916.02M
Enterprise Value
612.19M
Revenue
30.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.00
Market Cap Chart
Since December 11, 2020, AbCellera Biologics's market cap has decreased from 12.93B to 916.02M, a decrease of -92.92%. That is a compound annual growth rate of -41.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 936.88M | 12.08% |
| Dec 31, 2024 | 835.91M | -44.23% |
| Dec 29, 2023 | 1.50B | -44.72% |
| Dec 30, 2022 | 2.71B | -23.41% |
| Dec 31, 2021 | 3.54B | -60.02% |
| Dec 31, 2020 | 8.86B | -31.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 98.87B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.10B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |